[Preventive anticoagulation: example of risk/benefit analysis].
Suárez
C
C
Ruiz-Giménez
N
N
D000284:Administration, Oral; D000925:Anticoagulants / Q000627:therapeutic use*; D006801:Humans; D018570:Risk Assessment; D013927:Thrombosis / Q000517:prevention & control*; D014812:Vitamin K / Q000037:antagonists & inhibitors*; D014815:Vitamins / Q000037:antagonists & inhibitors*
D000925:Anticoagulants; D014815:Vitamins; D014812:Vitamin K